Glucotrol XL: Advanced Glycemic Control for Type 2 Diabetes
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.49 | $44.18 (0%) | 🛒 Add to cart |
| 120 | $0.44 | $58.90 $52.21 (11%) | 🛒 Add to cart |
| 180 | $0.38 | $88.35 $69.28 (22%) | 🛒 Add to cart |
| 270 | $0.35 | $132.53 $93.37 (30%) | 🛒 Add to cart |
| 360 | $0.33
Best per pill | $176.70 $118.47 (33%) | 🛒 Add to cart |
Synonyms | |||
Glucotrol XL (glipizide) is an extended-release oral medication designed for the management of hyperglycemia in type 2 diabetes mellitus. As a second-generation sulfonylurea, it facilitates controlled insulin secretion by targeting pancreatic beta cells, offering a predictable pharmacokinetic profile that supports sustained blood glucose reduction. Its advanced gastrointestinal therapeutic system (GITS) ensures a gradual release of glipizide, minimizing peak-trough fluctuations and supporting consistent 24-hour glycemic control. This formulation is particularly suited for patients requiring adjunctive therapy to diet and exercise, providing a reliable mechanism to lower HbA1c and fasting plasma glucose levels.
Features
- Contains glipizide as the active pharmaceutical ingredient in an extended-release formulation
- Utilizes a gastrointestinal therapeutic system (GITS) for controlled, zero-order drug delivery
- Available in 2.5 mg, 5 mg, and 10 mg tablet strengths
- Designed for once-daily dosing, supporting adherence and convenience
- Bioavailability remains unaffected by food, though consistent administration with breakfast is recommended
Benefits
- Promotes sustained insulin secretion in response to meals, reducing postprandial hyperglycemia
- Lowers both fasting and average blood glucose levels, contributing to improved HbA1c outcomes
- Minimizes the risk of sharp glucose fluctuations due to its extended-release mechanism
- Supports long-term glycemic stability, potentially reducing diabetes-related complications
- Offers dosing flexibility and simplicity, enhancing patient compliance
Common use
Glucotrol XL is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is typically prescribed when lifestyle modifications alone prove insufficient to achieve target glucose levels. It may be used as monotherapy or in combination with other antihyperglycemic agents, such as metformin, depending on individual therapeutic needs and tolerance.
Dosage and direction
The recommended starting dose for Glucotrol XL is 5 mg once daily, administered with breakfast. Dosage adjustments should be made in increments of 2.5–5 mg at intervals of at least several days, based on blood glucose response. The maximum recommended daily dose is 20 mg. Tablets must be swallowed whole and not crushed, chewed, or divided. Regular monitoring of blood glucose is advised to determine the optimal maintenance dose.
Precautions
- Regular blood glucose monitoring is essential to avoid hypoglycemia, especially during dose titration.
- Use with caution in elderly patients, debilitated individuals, and those with adrenal or pituitary insufficiency, due to increased hypoglycemia risk.
- Hepatic or renal impairment may alter drug metabolism and excretion; dose adjustment or alternative therapy may be necessary.
- Stressful conditions such as fever, trauma, or surgery may necessitate temporary discontinuation or insulin therapy.
- Periodic monitoring of liver function and hematologic parameters is recommended during long-term therapy.
Contraindications
Glucotrol XL is contraindicated in patients with:
- Known hypersensitivity to glipizide or other sulfonylureas
- Type 1 diabetes mellitus or diabetic ketoacidosis
- Severe renal or hepatic impairment
- Concurrent use of bosentan
Possible side effect
Common adverse reactions may include:
- Hypoglycemia
- Dizziness
- Headache
- Nausea
- Gastrointestinal discomfort
Less frequently, the following may occur:
- Skin reactions such as rash or pruritus
- Hematologic changes (e.g., leukopenia, thrombocytopenia)
- Elevated liver enzymes
- Hyponatremia (SIADH)
Drug interaction
Glucotrol XL may interact with:
- Drugs that increase hypoglycemia risk: insulin, other sulfonylureas, metformin, ACE inhibitors, fibrates, fluconazole, MAO inhibitors, salicylates, NSAIDs, probenecid, sulfonamides, warfarin
- Drugs that may increase blood glucose: thiazides, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers, isoniazid
- Drugs that may alter glipizide metabolism: CYP2C9 inhibitors (e.g., fluconazole) or inducers (e.g., rifampin)
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is near the time of the next dose, the missed dose should be skipped and the regular dosing schedule resumed. Doubling the dose is not recommended.
Overdose
Symptoms of overdose primarily include severe hypoglycemia, which may present as confusion, tremors, sweating, tachycardia, nausea, and seizures. Management involves immediate glucose administration (oral or intravenous) and close monitoring. In severe cases, hospitalization may be required.
Storage
Store at controlled room temperature (20–25°C or 68–77°F). Keep in a tightly closed container away from moisture, light, and excessive heat. Keep out of reach of children and pets.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or modifying any treatment regimen. Individual patient needs may vary.
Reviews
Clinical studies and patient reports indicate that Glucotrol XL is effective in maintaining glycemic control with a favorable side effect profile for many individuals. Patients often report improved consistency in daily glucose levels and appreciate the convenience of once-daily dosing. Healthcare providers value its predictable pharmacokinetics and utility in combination therapy regimens.